83 related articles for article (PubMed ID: 2834489)
1. [Use of a low molecular weight heparin, CY 222, in the treatment of consumption coagulopathy].
Audibert G; Lambert H; Toulemonde F; Alexandre P; Laprevote-Heully MC; Bollaert PE; Bauer P; Larcan A
J Mal Vasc; 1987; 12 Suppl B():147-51. PubMed ID: 2834489
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
Levi M; Toh CH; Thachil J; Watson HG
Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
[TBL] [Abstract][Full Text] [Related]
3. [Prophylactic and therapeutic use of a low molecular weight heparin fraction, CY 216].
Roussi J; Houbouyan L; Tereschenko C; Alterescu R; François D; Toulemonde F; Goguel A
J Mal Vasc; 1987; 12 Suppl B():123-7. PubMed ID: 2834483
[TBL] [Abstract][Full Text] [Related]
4. [Anticoagulation in hemodialysis sessions with a low molecular weight heparin (CY 222, Choay). Dosage studies in chronic hemodialysis. Its use in patients at high risk of hemorrhage].
Dieval J; Morinière P; Roussel B; Bayrou B; Fournier A; Delobel J
J Mal Vasc; 1987; 12 Suppl B():114-8. PubMed ID: 2834482
[TBL] [Abstract][Full Text] [Related]
5. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
Rodríguez Gómez M; López Fernández MF; Batlle J
Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of acute pulmonary embolism with a low molecular weight heparin by the intravenous route. Study of the optimal dosage].
Quilliet L; Charbonnier B; Delahousse B; Gruel Y; Brochier ML; Leroy J; Toulemonde F
Arch Mal Coeur Vaiss; 1988 Oct; 81(10):1219-25. PubMed ID: 2851965
[TBL] [Abstract][Full Text] [Related]
8. [Freshly frozen preserved plasma for the treatment of intravascular coagulation in polytraumatized patients].
Hehne HJ; Nyman D; Burri H; Wolff G
Schweiz Med Wochenschr; 1976 May; 106(20):671-6. PubMed ID: 996489
[TBL] [Abstract][Full Text] [Related]
9. [Use in hemodialysis and hemofiltration of CY 216 (Fraxiparine) administered via intravenous bolus in patients with acute and chronic renal insufficiency with and without hemorrhagic risk].
Steinbach G; Bosc C; Caraman PL; Azoulay E; Olry L; D'Azemar P; Chopin J
Nephrologie; 1990; 11(1):17-21. PubMed ID: 2165223
[TBL] [Abstract][Full Text] [Related]
10. [Low molecular weight heparin fractions. Comparative preclinical study of various parameters].
Fareed J
J Mal Vasc; 1987; 12 Suppl B():59-63. PubMed ID: 2834492
[TBL] [Abstract][Full Text] [Related]
11. [Plasma exchange with very low molecular weight heparin CY 222. Biological profile and therapeutic value].
Assogba U; Crespo B; Bayrou B; Binet JL; Rottembourg J
Ann Med Interne (Paris); 1988; 139 Suppl 1():66-8. PubMed ID: 2854713
[TBL] [Abstract][Full Text] [Related]
12. [Consumption coagulopathies following peritoneojugular bypass. Prevention by a heparin-antithrombin III combination].
Peyrin JC; Waldmann V; Girardet P; Pouzol P; Duret J; Fargnoli JM; Magne JL; Perron Y
J Chir (Paris); 1986; 123(6-7):417-23. PubMed ID: 3771670
[TBL] [Abstract][Full Text] [Related]
13. Blood coagulation and thrombosis in patients with ovarian malignancy.
von Tempelhoff GF; Dietrich M; Niemann F; Schneider D; Hommel G; Heilmann L
Thromb Haemost; 1997 Mar; 77(3):456-61. PubMed ID: 9065993
[TBL] [Abstract][Full Text] [Related]
14. Treatment of disseminated intravascular coagulation with low molecular weight heparin. Research Group of FR-860 on DIC in Japan.
Oguma Y; Sakuragawa N; Maki M; Hasegawa H; Nakagawa M
Semin Thromb Hemost; 1990 Oct; 16 Suppl():34-40. PubMed ID: 1962902
[TBL] [Abstract][Full Text] [Related]
15. Fresh frozen plasma should be given earlier to patients requiring massive transfusion.
Gonzalez EA; Moore FA; Holcomb JB; Miller CC; Kozar RA; Todd SR; Cocanour CS; Balldin BC; McKinley BA
J Trauma; 2007 Jan; 62(1):112-9. PubMed ID: 17215741
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
17. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary study of the use of low-molecular weight heparin to prevent thrombotic risk].
Delahousse B; Gruel Y; Moalic P; Foloppe P; Leclerc MH; Guerois C; Fimbel B; Leroy J
J Mal Vasc; 1986; 11(4):330-7. PubMed ID: 3805895
[TBL] [Abstract][Full Text] [Related]
19. [The treatment of the disseminated intravascular coagulation syndrome in urosepsis patients].
Neĭmark AI; Astakhov IuI; Mazyrko AV
Urol Nefrol (Mosk); 1990; (4):13-7. PubMed ID: 2275053
[TBL] [Abstract][Full Text] [Related]
20. A comparison between low molecular weight heparin (KABI 2165) and standard heparin in the intravenous treatment of deep venous thrombosis.
Bratt G; Törnebohm E; Granqvist S; Aberg W; Lockner D
Thromb Haemost; 1985 Dec; 54(4):813-7. PubMed ID: 3911482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
